Search hospitals > California > Los Angeles
University of California, Los Angeles
Claim this profileLos Angeles, California 90095
Global Leader in Cancer
Global Leader in Parotid Gland Cancer
Conducts research for Lymphoma
Conducts research for Melanoma
Conducts research for Cystic Tumor
1327 reported clinical trials
145 medical researchers
Summary
University of California, Los Angeles is a medical facility located in Los Angeles, California. This center is recognized for care of Cancer, Parotid Gland Cancer, Lymphoma, Melanoma, Cystic Tumor and other specialties. University of California, Los Angeles is involved with conducting 1,327 clinical trials across 1,490 conditions. There are 145 research doctors associated with this hospital, such as Jacqueline N. Casillas, Zev A. Wainberg, Gary Schiller, MD, and Theodore Moore, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
FGFR3 positive
2Parotid Gland Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
Top PIs
Jacqueline N. CasillasMiller Children's and Women's Hospital Long Beach8 years of reported clinical research
Expert in Cystic Tumor
Expert in Cancer
48 reported clinical trials
97 drugs studied
Zev A. WainbergUCLA3 years of reported clinical research
Expert in Pancreatic Cancer
Expert in Solid Tumors
33 reported clinical trials
65 drugs studied
Gary Schiller, MDUCLA Medical Center7 years of reported clinical research
Expert in Acute Myelogenous Leukemia
Expert in Adult T-Cell Leukemia/Lymphoma
31 reported clinical trials
52 drugs studied
Theodore Moore, MDMattel Children's Hospital UCLA8 years of reported clinical research
Studies Cystic Tumor
Studies Cancer
21 reported clinical trials
59 drugs studied
Clinical Trials running at University of California, Los Angeles
Lymphoma
Cancer
Melanoma
Chronic Lymphocytic Leukemia
Coronavirus
Giant Cell Tumor
Non-Small Cell Lung Cancer
Idiopathic Pulmonary Fibrosis
Mediastinal Lymphoma
Lymphoid Hematopoietic Disease
Long-term Ibrutinib
for Lymphoma
This trial aims to provide ongoing access to ibrutinib for patients who have benefited from it in previous studies. Ibrutinib is an oral medication that blocks a protein involved in cancer growth, helping to slow or stop the disease. The study will monitor safety and effectiveness over time. Ibrutinib has been studied extensively and is used to treat various B cell malignancies, including chronic lymphocytic leukemia and mantle cell lymphoma.
Recruiting2 awards Phase 35 criteria
Axicabtagene Ciloleucel
for Lymphoma
The goal of this clinical study is to compare the study drug, axicabtagene ciloleucel, versus standard of care (SOC) in first-line therapy in participants with high-risk large B-cell lymphoma.
Recruiting2 awards Phase 3
Targeted Immunotherapy
for Leukemia
A Phase I trial to determine the safety of targeted immunotherapy with daratumumab (DARA) IV after total body irradiation (TBI)-based myeloablative conditioning and allogeneic hematopoietic cell transplantation (HCT) for children, adolescents, and young adults (CAYA) with high risk T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LLy). Pre- and post-HCT NGS-MRD studies will be correlated with outcomes in children, adolescents, and young adults with T-ALL undergoing allogeneic HCT and post-HCT DARA treatment. The study will also evaluate T-cell repertoire and immune reconstitution prior to and following DARA post-HCT treatment and correlate with patient outcomes.
Recruiting2 awards Phase 17 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of California, Los Angeles?
Where is University of California, Los Angeles located?
Who should I call to ask about financial aid or insurance network?
What insurance does University of California, Los Angeles accept?
What awards or recognition has University of California, Los Angeles received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.